Ling Xie

5.1k total citations
48 papers, 1.4k citations indexed

About

Ling Xie is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ling Xie has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Ling Xie's work include Protein Degradation and Inhibitors (18 papers), Ubiquitin and proteasome pathways (14 papers) and RNA modifications and cancer (6 papers). Ling Xie is often cited by papers focused on Protein Degradation and Inhibitors (18 papers), Ubiquitin and proteasome pathways (14 papers) and RNA modifications and cancer (6 papers). Ling Xie collaborates with scholars based in United States, China and Israel. Ling Xie's co-authors include Xian Chen, Jian Jin, Jing Liu, H. Ümit Kanıskan, Wenyi Wei, He Chen, Xiaoran Han, Yue Xiong, Xufen Yu and Yanbao Yu and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Ling Xie

45 papers receiving 1.3k citations

Peers

Ling Xie

ONCOL

IMMUN

HEMAT

Boris Shor United States

Marie-Ève Beaulieu Spain

Nathaniel Robichaud Canada

Rob C. Laister Canada

Troy Ketela Canada

Andrew J.K. Williamson United Kingdom

Т. А. Смирнова Russia

Dwight M. Morrow United States

Amila Suraweera Australia

Karen A. Olson United States

Boris Shor United States

Ling Xie

946 ×0.9

272 ×0.9

ONCOL

85 ×0.5

151 ×0.8

IMMUN

61 ×0.5

HEMAT

Citations per year, relative to Ling Xie Ling Xie (= 1×) peers Boris Shor

Countries citing papers authored by Ling Xie

Since Specialization

Citations

This map shows the geographic impact of Ling Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Xie more than expected).

Fields of papers citing papers by Ling Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Xie. The network helps show where Ling Xie may publish in the future.

Co-authorship network of co-authors of Ling Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Xie. A scholar is included among the top collaborators of Ling Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Xie. Ling Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Han, Yulin, Yue Zhong, Joel Hrit, et al.. (2025). Structure–Activity Relationship Studies of DNA Methyltransferase 1 Monovalent Degraders. Journal of Medicinal Chemistry. 68(3). 2903–2919.

Xue, Zhaoyu, Mengying Huang, Ling Xie, et al.. (2024). A potent and selective ENL degrader suppresses oncogenic gene expression and leukemia progression. Science Advances. 10(35). eado1432–eado1432. 1 indexed citations

Xie, Ling, Ming Zhang, Qiaoqiao Liu, et al.. (2023). Downregulation of ciRNA‐Kat6b in dorsal spinal horn is required for neuropathic pain by regulating Kcnk1 in miRNA‐26a‐dependent manner. CNS Neuroscience & Therapeutics. 29(10). 2955–2971. 8 indexed citations

Wang, Zhen, Jing Liu, He Chen, et al.. (2023). Telomere Targeting Chimera Enables Targeted Destruction of Telomeric Repeat-Binding Factor Proteins. Journal of the American Chemical Society. 145(19). 10872–10879. 19 indexed citations

Wang, Zhen, Jing Liu, Xing Qiu, et al.. (2023). Methylated Nucleotide-Based Proteolysis-Targeting Chimera Enables Targeted Degradation of Methyl-CpG-Binding Protein 2. Journal of the American Chemical Society. 145(40). 21871–21878. 9 indexed citations

Liu, Jing, Xufen Yu, He Chen, et al.. (2022). TF-DUBTACs Stabilize Tumor Suppressor Transcription Factors. Journal of the American Chemical Society. 144(28). 12934–12941. 42 indexed citations

Dale, Brandon, Kwang‐Su Park, H. Ümit Kanıskan, et al.. (2022). Targeting Triple-Negative Breast Cancer by a Novel Proteolysis Targeting Chimera Degrader of Enhancer of Zeste Homolog 2. ACS Pharmacology & Translational Science. 5(7). 491–507. 32 indexed citations

Liu, Jing, He Chen, H. Ümit Kanıskan, et al.. (2021). TF-PROTACs Enable Targeted Degradation of Transcription Factors. Journal of the American Chemical Society. 143(23). 8902–8910. 178 indexed citations

Chou, Wei-Chun, Zengli Guo, Hao Guo, et al.. (2021). AIM2 in regulatory T cells restrains autoimmune diseases. Nature. 591(7849). 300–305. 125 indexed citations

10.

Han, Xiaoran, Naoya Sasaki, Sarah Jackson, et al.. (2020). CRL4 ^DCAF1/VprBP E3 ubiquitin ligase controls ribosome biogenesis, cell proliferation, and development. Science Advances. 6(51). 31 indexed citations

11.

Xie, Ling, et al.. (2020). FOLR1 was up-regulated in cervical squamous cell carcinoma and correlated with the patients’ progression free survival. SHILAP Revista de lepidopterología. 31(1). 100–108. 1 indexed citations

12.

Wang, Tengyue, Lijuan Wei, Jia Wang, et al.. (2020). Integrating GWAS, linkage mapping and gene expression analyses reveals the genetic control of growth period traits in rapeseed (Brassica napus L.). Biotechnology for Biofuels. 13(1). 134–134. 26 indexed citations

13.

Chen, Meiling, et al.. (2020). LINC00324 facilitates cell proliferation through competing for miR‑214‑5p in immature ovarian teratocarcinoma. International Journal of Molecular Medicine. 47(1). 397–407. 10 indexed citations

14.

Hu, Lianxin, Haibiao Xie, Xijuan Liu, et al.. (2019). TBK1 Is a Synthetic Lethal Target in Cancer with VHL Loss. Cancer Discovery. 10(3). 460–475. 72 indexed citations

15.

Pan, Zhiqiang, Ling Xie, Di Liu, et al.. (2019). MicroRNA-1224 Splicing CircularRNA-Filip1l in an Ago2-Dependent Manner Regulates Chronic Inflammatory Pain via Targeting Ubr5. Journal of Neuroscience. 39(11). 2125–2143. 72 indexed citations

16.

Wang, Li, Ling Xie, Srinivas Ramachandran, et al.. (2015). Non-canonical Bromodomain within DNA-PKcs Promotes DNA Damage Response and Radioresistance through Recognizing an IR-Induced Acetyl-Lysine on H2AX. Chemistry & Biology. 22(7). 849–861. 13 indexed citations

17.

Xie, Ling, Peng Wang, & Xiaoqing Pan. (2014). A perturbation theory study of electron vortices in electromagnetic fields: The case of infinitely long line charge and magnetic dipole. Micron. 63. 9–14. 2 indexed citations

18.

Xie, Ling, Jundong Zhou, Shuyu Zhang, et al.. (2014). Integrating microRNA and mRNA expression profiles in response to radiation-induced injury in rat lung. Radiation Oncology. 9(1). 111–111. 32 indexed citations

19.

Gunawardena, Harsha P., Yi Huang, Roma Kenjale, et al.. (2011). Unambiguous Characterization of Site-specific Phosphorylation of Leucine-rich Repeat Fli-I-interacting Protein 2 (LRRFIP2) in Toll-like Receptor 4 (TLR4)-mediated Signaling. Journal of Biological Chemistry. 286(13). 10897–10910. 24 indexed citations

20.

Dai, Penggao, Sun Yong Jeong, Yanbao Yu, et al.. (2009). Modulation of TLR Signaling by Multiple MyD88-Interacting Partners Including Leucine-Rich Repeat Fli-I-Interacting Proteins. The Journal of Immunology. 182(6). 3450–3460. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact